US Health Secretary Kennedy: new drug-pricing deals include $19.6BN commitments
U.S. Health Secretary Kennedy says new drug-pricing deals include $19.6BN in commitments to reshore pharmaceutical production to the U.S.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.